BTZ
Showing 26 - 37 of 37
Relapse/Refractory Multiple Myeloma Trial in Japan (LBH589 (panobinostat), bortezomib, dexamethasone)
Completed
- Relapse/Refractory Multiple Myeloma
- LBH589 (panobinostat)
- +2 more
-
Nagoya-city, Aichi, Japan
- +19 more
Oct 28, 2019
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Completed
- Fallopian Tube Clear Cell Adenocarcinoma
- +19 more
- Bortezomib
- +3 more
-
Hartford, Connecticut
- +13 more
Aug 8, 2019
Infections, Respiratory Tract Trial in London (GSK2140944 for Injection, GSK2140944 Capsule)
Completed
- Infections, Respiratory Tract
- GSK2140944 for Injection
- GSK2140944 Capsule
-
London, United KingdomGSK Investigational Site
Jul 10, 2017
Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse Trial in United
Completed
- Relapsed and Bortezomib Refractory Multiple Myeloma
- +2 more
- panobinostat
- +2 more
-
Los Angeles, California
- +12 more
Nov 27, 2017
Infections, Bacterial Trial in Baltimore (GSK2140944 (Single dose), GSK2140944 (Multiple dose))
Completed
- Infections, Bacterial
- GSK2140944 (Single dose)
- GSK2140944 (Multiple dose)
-
Baltimore, MarylandGSK Investigational Site
May 12, 2017
Infections, Respiratory Tract Trial in Overland Park (GSK2140944, Placebo)
Completed
- Infections, Respiratory Tract
- GSK2140944
- Placebo
-
Overland Park, KansasGSK Investigational Site
May 5, 2017
Infections, Respiratory Tract Trial in Minneapolis (GSK2140944, Placebo)
Completed
- Infections, Respiratory Tract
- GSK2140944
- Placebo
-
Minneapolis, MinnesotaGSK Investigational Site
Jun 9, 2017
Kidney Transplantation Trial in Rochester (Bortezomib)
Completed
- Kidney Transplantation
-
Rochester, MinnesotaMayo Clinic
Apr 28, 2016